ALFACYTE Trademark

Trademark Overview


On Thursday, September 16, 2021, a trademark application was filed for ALFACYTE with the United States Patent and Trademark Office. The USPTO has given the ALFACYTE trademark a serial number of 79327654. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by ILC Therapeutics Limited. The ALFACYTE trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases and disorders of the respiratory system; anti-viral agents relating to the treatment of cancer, respiratory diseases and dermatitis; pharmaceutical drugs relating to the treatment of cancer, respiratory diseases and dermatitis; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicines for human purposes relating to the treatment of cancer, respiratory diseases and dermatitis; pharmaceutical preparations containing alpha interferon for the treatment of cancer and respiratory diseases; medicines for treating inflammatory diseases; pharmaceutical preparations for treating inflammatory diseases
alfacyte

General Information


Serial Number79327654
Word MarkALFACYTE
Filing DateThursday, September 16, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7008476
Registration DateTuesday, March 28, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesMedicines for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the prevention of diseases and disorders of the respiratory system; anti-viral agents relating to the treatment of cancer, respiratory diseases and dermatitis; pharmaceutical drugs relating to the treatment of cancer, respiratory diseases and dermatitis; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicines for human purposes relating to the treatment of cancer, respiratory diseases and dermatitis; pharmaceutical preparations containing alpha interferon for the treatment of cancer and respiratory diseases; medicines for treating inflammatory diseases; pharmaceutical preparations for treating inflammatory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameILC Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameILC Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameILC Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, June 21, 2022ASSIGNED TO EXAMINER
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Thursday, June 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 25, 2022REFUSAL PROCESSED BY MPU
Saturday, June 25, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 19, 2022REFUSAL PROCESSED BY IB
Tuesday, November 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Thursday, December 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, June 28, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 18, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 18, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 7, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 21, 2025NEW REPRESENTATIVE AT IB RECEIVED